Literature DB >> 315944

Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor.

H T Haigler, J A McKanna, S Cohen.   

Abstract

Horseradish peroxidase (HRP) uptake was used to measure fluid-phase pinocytosis in monolayers of human epithelioid carcinoma cells (A-431). Histochemistry confirmed that cell-associated HRP was restricted to intracellular vesicles. Biochemical methods showed that HRP uptake in control cultures was directly proportional to the duration of exposure. The addition of low concentrations of epidermal growth factor (EGF) to the incubation media produced a 10-fold increase in the initial rate of pinocytosis. The EGF effect was rapid (within 30 s) but transient; the rate of pinocytosis returned to control levels within 15 min. Metabolic inhibitors reduced the EGF-stimulated rate of pinocytosis by greater than 90%. A conjugate of EGF and ferritin (F:EGF) was used to simultaneously compare the intracellular locations of EGF and HRP. Much of F:EGF was internalized in approximately 100-nm vesicles, while most of the HRP was located in much larger vesicles (range 0.1--1.2 micrometer) which also contained F:EGF. The tumor-promoter 12-0-tetradecanoyl-phorbol-13-acetate, which shares several biological activities with EGF, was also effective in stimulating an increase in the rate of pinocytosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315944      PMCID: PMC2110451          DOI: 10.1083/jcb.83.1.82

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  25 in total

1.  Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells.

Authors:  J Schlessinger; Y Shechter; M C Willingham; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro.

Authors:  G Carpenter; L King; S Cohen
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

3.  Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors.

Authors:  L S Lee; I B Weinstein
Journal:  Science       Date:  1978-10-20       Impact factor: 47.728

4.  Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells.

Authors:  L S Lee; I B Weinstein
Journal:  Nature       Date:  1978-08-17       Impact factor: 49.962

5.  Molecular mechanism of mitogen action: processing of receptor induced by epidermal growth factor.

Authors:  M Das; C F Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Stimulation of DNA synthesis by tumour promoter and pure mitogenic factors.

Authors:  P Dicker; E Rozengurt
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

7.  Amines inhibit the clustering of alpha2-macroglobulin and EGF on the fibroblast cell surface.

Authors:  F R Maxfield; M C Willingham; P J Davies; I Pastan
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

8.  Influence of epidermal growth factor (EGF) on ruffling activity, pinocytosis and proliferation of cultivated human glia cells.

Authors:  U Brunk; J Schellens; B Westermark
Journal:  Exp Cell Res       Date:  1976-12       Impact factor: 3.905

9.  Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431.

Authors:  H Haigler; J F Ash; S J Singer; S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

10.  Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431.

Authors:  H T Haigler; J A McKanna; S Cohen
Journal:  J Cell Biol       Date:  1979-05       Impact factor: 10.539

View more
  98 in total

1.  Circulation of the plasma membrane in Dictyostelium.

Authors:  C Aguado-Velasco; M S Bretscher
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

2.  Differential endocytotic characteristics of a novel human B/DC cell line HBM-Noda: effective macropinocytic and phagocytic function rather than scavenging function.

Authors:  I Torii; S Morikawa; M Nagasaki; A Nokano; K Morikawa
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

3.  Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.

Authors:  Dhaval K Shah; Alison M Betts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-06       Impact factor: 2.745

Review 4.  The pervasiveness of macropinocytosis in oncological malignancies.

Authors:  Cosimo Commisso
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-04       Impact factor: 6.237

5.  Interaction of ezrin with the novel guanine nucleotide exchange factor PLEKHG6 promotes RhoG-dependent apical cytoskeleton rearrangements in epithelial cells.

Authors:  Romina D'Angelo; Sandra Aresta; Anne Blangy; Laurence Del Maestro; Daniel Louvard; Monique Arpin
Journal:  Mol Biol Cell       Date:  2007-09-19       Impact factor: 4.138

6.  Mesangial cell activation by bacterial endotoxin. Induction of rapid cytoskeletal reorganization and gene expression.

Authors:  S L Bursten; F Stevenson; F Torrano; D H Lovett
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

7.  Origins of growth factors: NGF and EGF.

Authors:  Stanley Cohen
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

Review 8.  Abi1, a critical molecule coordinating actin cytoskeleton reorganization with PI-3 kinase and growth signaling.

Authors:  Leszek Kotula
Journal:  FEBS Lett       Date:  2012-05-19       Impact factor: 4.124

9.  Effect of anti-GMP antibodies on the growth of transformed cells.

Authors:  K C Kala; A Antony
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-04       Impact factor: 2.416

10.  Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation.

Authors:  E Merit Reyes-Reyes; Francesca R Šalipur; Mitra Shams; Matthew K Forsthoefel; Paula J Bates
Journal:  Mol Oncol       Date:  2015-04-09       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.